Episode 2: Matt speaks with Avoro Capital's Behzad Aghazadeh about the hot button issues that have been striking the biotech sector

from Off-Target Effects with Matt Gline · host BiotechTV

One of the largest and most successful biotech investors, Dr. Aghazadeh is asked about key current events like turnover at FDA, tariffs, China, and whether he thinks biotech has a structural problem regarding how companies 'innovate' today and the different market strategies of investors.

Episode metadata supplied by the publisher feed · Published Apr 10, 2025

Embed this episode

Attribution link and audio player

Ready to play

Episode 2: Matt speaks with Avoro Capital's Behzad Aghazadeh about the hot button issues that have been striking the biotech sector

0:00 33:50

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Off-Target Effects with Matt Gline?

This episode is 33 minutes long.

When was this Off-Target Effects with Matt Gline episode published?

This episode was published on April 10, 2025.

Can I download this Off-Target Effects with Matt Gline episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!